Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2005-06-28
2005-06-28
Andres, Janet (Department: 1646)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S085400
Reexamination Certificate
active
06911198
ABSTRACT:
A method of treating an inflammation in a subject in need thereof is disclosed. The method comprises locally or systemically administering to the subject IFN-γ in an amount so as to achieve an IFN-γ bulk tissue concentration at a site of inflammation of 1-8,000 units per kilogram body weight, thereby ameliorating the inflammation.
REFERENCES:
patent: 4921697 (1990-05-01), Peterlik et al.
patent: 5145677 (1992-09-01), von Eichborn et al.
patent: 6121247 (2000-09-01), Huang et al.
patent: 01/23006 (2001-04-01), None
patent: 01/34180 (2001-05-01), None
Paulnock et al., J. Interferon Res. 1989, vol. 9, pp. 457-473.
Melmon et al., Principles of Therapeutics, pp. 40-55, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 1980.
ACTIMMUNE package insert, 2003.
Placebo-Associated Remissions in a Multicentre, Randomized, Double-Blind Trial of Interferon γ-1 b for the Treatment of Metastatic Renal Cell Carcinoma, Elhilali et al., BJU International, 2000, 86, pp 613-618.
Complete Response of Metastatic Renal Cell Carcinoma to Low-Dose Interferon-γ Treatment, Otto, et al., Cancer Immunol Immunother, 1995, 40: pp 115-118.
Renal Cell Carcinoma and Interferon at the Millennium, Pastore, et al., Cancer Investigation, 19(3) 2001, pp 281-291.
The Treatment of Metastatic Renal Cell Carcinoma Patients with Recombinant Human Gamma Interferon, Small, et al., Cancer J. Sci. Am., 1998, May-Jun., 4(3), 155-6.
A Preliminary Study of Long-Term Treatment with Interferon Gamma-1 b and Low-Dose Prednisolone in Pateitns with Idiopathic Pulmonary Fibrosis, Ziesche, et al., The New England Journal of Medicine, Oct. 21, 1999, vol. 341, No. 17, pp 1264-1269.
Flaishon Liat
Shachar Idit
Andres Janet
G.E. Ehrlich (1995) Ltd.
Yeda Research and Development Co. Ltd.
LandOfFree
Method and pharmaceutical composition for treating inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and pharmaceutical composition for treating inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and pharmaceutical composition for treating inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3466074